Nutriband Inc. Amends Bylaws to Authorize Series A Preferred Stock

Reuters
16 Jul
<a href="https://laohu8.com/S/NTRB">Nutriband Inc.</a> Amends Bylaws to Authorize Series A Preferred Stock

Nutriband Inc. has announced amendments to its Articles of Incorporation, as approved by the Board of Directors on July 9, 2025. The company will introduce a new series of non-voting shares of Preferred Stock, known as Series A Convertible Preferred Stock, with a par value of $0.001 per share. A total of 2,788,678 shares of Series A Preferred Stock have been authorized. Additionally, a preferred stock dividend will be issued, granting shareholders one share of Series A Preferred Stock for every four shares of common stock held. The conversion of Series A Preferred Stock into common stock will be possible after the commercial approval of the company's transdermal pharmaceutical products by the FDA.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutriband Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-064355), on July 16, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10